Use of Cervical Fascia to Prevent Pharyngocutaneus Fistula After Total Laryngectomy

Basit Öğe Kaydı
dc.authoridDALGIC, ABDULLAH/0000-0002-6958-4169
dc.authoridaysel, abdulhalim/0000-0001-8584-308X
dc.authoridKertmen, Canberk/0009-0005-5413-0139
dc.authoridYIlmaz, FAtih/0000-0001-5303-961X
dc.authoridMuderris, Togay/0000-0003-4014-8176
dc.authoridZorlu, Mehmet Ekrem/0000-0003-0474-8094
dc.contributor.authorZorlu, Mehmet Ekrem
dc.contributor.authorKertmen, Canberk
dc.contributor.authorAysel, Abdulhalim
dc.contributor.authorYilmaz, Fatih
dc.contributor.authorDalgic, Abdullah
dc.contributor.authorMuderris, Togay
dc.date.accessioned2025-03-20T09:51:25Z
dc.date.available2025-03-20T09:51:25Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesi
dc.description.abstractObjective: This study aimed to compare the pharyngocutaneous fistula (PCF) between patients who underwent reconstruction using cervical fascia after total laryngectomy and those who did not and to investigate the factors affecting PCF rates. Methods: We retrospectively compared 22 patients operated between February 2021 and March 2023 who received cervical fascia flap as the study group and 21 patients operated between January 2018 and March 2023 who did not receive fascia flap as the control group. The study included patients who underwent total laryngectomy for Stage 3 and 4 squamous cell laryngeal cancer. Results: We included 43 patients, with 22 (51.2%) and 21 patients (48.8%) in the study and control groups, respectively. The age and sex were not different between the two groups (p=0.471, p=0.176, respectively). The distribution of patients as per sex, smoking, alcohol use, chronic obstructive pulmonary disease, diabetes mellitus, coronary artery disease, and multiple comorbidities was similar in both groups (p>0.05). PCF was observed in one patient (4.5%) and seven patients (33.3%) in the study and control groups, respectively. The PCF rate was significantly lower in the study group (p=0.021). When the relationship between flap use and risk factors was compared by correlation analysis, a moderate negative relationship was found between flap use and PCF (p=0.015, r=-0.370). Conclusion: The use of a cervical fascia flap is effective in reducing fistula rates after total laryngectomy. Its main advantages include being technically simpler than alternative techniques, locally available, cost-effective.
dc.identifier.doi10.1002/lary.31606
dc.identifier.endpage4970
dc.identifier.issn0023-852X
dc.identifier.issn1531-4995
dc.identifier.issue12
dc.identifier.pmid38940495
dc.identifier.scopus2-s2.0-85197403036
dc.identifier.scopusqualityQ1
dc.identifier.startpage4964
dc.identifier.urihttps://doi.org/10.1002/lary.31606
dc.identifier.urihttps://hdl.handle.net/20.500.14034/2535
dc.identifier.volume134
dc.identifier.wosWOS:001258197800001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofLaryngoscope
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250319
dc.subjectlarynx
dc.subjectlaryngeal cancer
dc.subjectvocal fold dysplasia
dc.subjectneoplasia
dc.subjectmalignancy
dc.titleUse of Cervical Fascia to Prevent Pharyngocutaneus Fistula After Total Laryngectomy
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu